InvestorsHub Logo
Followers 80
Posts 24704
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Thursday, 03/04/2021 8:01:56 AM

Thursday, March 04, 2021 8:01:56 AM

Post# of 27623
LPCN - 1.43 Pre-market at 1.49/1.50

Lipocine Announces Publication in Journal of Endocrinological Investigation Highlighting the Potential of LPCN 1144 in the Treatment of NASH and Hepatic Fibrosis

https://stockcharts.com/h-sc/ui?s=lpcn
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.